Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
McKinsey
Baxter
Express Scripts
AstraZeneca

Last Updated: February 1, 2023

Litigation Details for Eagle Pharmaceuticals, Inc. v. Hospira, Inc. (D. Del. 2018)


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Small Molecule Drugs cited in Eagle Pharmaceuticals, Inc. v. Hospira, Inc.
The small molecule drugs covered by the patents cited in this case are See Plans and Pricing and See Plans and Pricing .

Details for Eagle Pharmaceuticals, Inc. v. Hospira, Inc. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-12-27 108 Order constructions for certain terms in U.S. Patent No. 9,572,887 (the “887 patent”), and the Court held a Markman…2018 19 April 2022 1:18-cv-01074 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff External link to document
2022-04-20 160 Patent/Trademark Report to Commissioner of Patents Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,572,887 B2; US 10,010,533 B2; US 9,034,908…2018 19 April 2022 1:18-cv-01074 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff External link to document
2019-12-15 35 Memorandum Opinion 1 U.S. Patent Nos. 10,010,533 (the "#533 patent"), 9,034,908 (the "#908 patent"),…quot;#568 patent"), 9,597,397 (the "#397 patent"), 9,597,398 (the "#398 patent")…#399 patent"), 9,000,021 (the "#021 patent"), and 9,579,384 (the ·"#384 patent"… The ninth asserted patent, U.S. Patent No. 9,572,887 (the "#887 patent"), requires a "…quot;). to these patents as the "PG patents." In Counts II through IX and XI through XVIII of External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
McKesson
Express Scripts
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.